The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Meeder Advisory Services Inc.

Meeder Advisory Services Inc. lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 9.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,734 shares of the medical device company’s stock after buying an additional 331 shares during the period. Meeder Advisory Services Inc.’s holdings in Cooper Companies were worth $326,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its position in Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after acquiring an additional 17,367,502 shares during the period. Capital World Investors grew its holdings in shares of Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after purchasing an additional 4,246,519 shares during the period. Janus Henderson Group PLC increased its position in Cooper Companies by 279.8% during the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after purchasing an additional 2,532,186 shares in the last quarter. Bessemer Group Inc. raised its holdings in Cooper Companies by 305.2% in the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after buying an additional 1,507,049 shares during the period. Finally, Swedbank AB acquired a new position in Cooper Companies during the first quarter valued at approximately $139,246,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cooper Companies

In other news, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at $700,422.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The disclosure for this sale can be found here. Insiders sold a total of 141,381 shares of company stock worth $14,927,361 over the last 90 days. Insiders own 2.00% of the company’s stock.

Cooper Companies Price Performance

Shares of COO stock opened at $110.53 on Monday. The firm has a fifty day moving average of $95.59 and a two-hundred day moving average of $95.09. The firm has a market cap of $22.01 billion, a P/E ratio of 65.02, a P/E/G ratio of 2.60 and a beta of 0.98. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $110.69. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same period last year, the firm earned $0.84 earnings per share. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.66 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently commented on COO. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Morgan Stanley boosted their price objective on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and increased their target price for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Piper Sandler boosted their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $115.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.